创新药板块止跌回暖，关注创新药ETF易方达和恒生创新药ETF（159316）等投资价值

Group 1 - The innovative drug sector has rebounded today, with various indices showing positive growth, including a 2.8% increase in the China Securities Hong Kong Stock Connect Medical and Health Comprehensive Index [1] - The China Securities Innovative Drug Industry Index rose by 2.7%, while the Hang Seng Hong Kong Stock Connect Innovative Drug Index increased by 2.5% [1] - The China Securities Biotechnology Theme Index and the CSI 300 Medical and Health Index also saw gains of 2.1% and 1.8% respectively [1] Group 2 - The innovative drug ETFs, such as E Fund (516080) and Hang Seng Innovative Drug ETF (159316), have experienced continuous net inflows for 4 and 5 trading days respectively [1]